Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
19 hedge funds and large institutions have $8.3M invested in Intellipharmaceuticals International Inc. in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
46% more funds holding
Funds holding: 13 → 19 (+6)
26% more capital invested
Capital invested by funds: $6.58M → $8.3M (+$1.72M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
57% less call options, than puts
Call options by funds: $123K | Put options by funds: $287K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$332K |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$187K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$171K |
| 4 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$103K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$43.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$278K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$120K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$40K |
| 4 |
Citigroup
New York
|
-$3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
IPCI Hedge Fund Activity: Q1 2014 in Review
19 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2014, worth a combined $8.3M — up 26% from $6.58M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IPCI positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $332K. The largest seller was Deutsche Bank, cutting an estimated $278K.
- 19 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2014, up from 13 in Q4 2013.
- Funds reported $8.3M of Intellipharmaceuticals International Inc. stock for Q1 2014, up 26% quarter-over-quarter.
- 8 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2014 and 2 closed out, a net change of +6 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q1 2014 was Morgan Stanley, an estimated $332K added.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2014 was Deutsche Bank, an estimated $278K sold.
Based on aggregated 13F filings for Q1 2014.